Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

David R Powell, Deon Doree, Sabrina Jeter-Jones, Zhi-Ming Ding, Brian Zambrowicz, Arthur Sands Lexicon Pharmaceuticals, The Woodlands, TX, USA Purpose: Oral agents are needed that improve glycemic control without increasing hypoglycemic events in patients with type 1 diabetes (T1D). Sotagliflozin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/1034519483334cc29f9be744afccfd80
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!